Boston Scientific (BSX) Competitors $97.84 +0.13 (+0.13%) As of 01:27 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BSX vs. ALGN, HOLX, HQY, MMSI, AMN, CAH, DVA, ECL, HCA, and MDTShould you be buying Boston Scientific stock or one of its competitors? The main competitors of Boston Scientific include Align Technology (ALGN), Hologic (HOLX), HealthEquity (HQY), Merit Medical Systems (MMSI), AMN Healthcare Services (AMN), Cardinal Health (CAH), DaVita (DVA), Ecolab (ECL), HCA Healthcare (HCA), and Medtronic (MDT). Boston Scientific vs. Its Competitors Align Technology Hologic HealthEquity Merit Medical Systems AMN Healthcare Services Cardinal Health DaVita Ecolab HCA Healthcare Medtronic Align Technology (NASDAQ:ALGN) and Boston Scientific (NYSE:BSX) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, institutional ownership, earnings, media sentiment, valuation, risk and analyst recommendations. Do institutionals & insiders have more ownership in ALGN or BSX? 88.4% of Align Technology shares are held by institutional investors. Comparatively, 89.1% of Boston Scientific shares are held by institutional investors. 0.7% of Align Technology shares are held by insiders. Comparatively, 0.5% of Boston Scientific shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Is ALGN or BSX more profitable? Boston Scientific has a net margin of 13.55% compared to Align Technology's net margin of 11.04%. Boston Scientific's return on equity of 19.21% beat Align Technology's return on equity.Company Net Margins Return on Equity Return on Assets Align Technology11.04% 13.36% 8.32% Boston Scientific 13.55%19.21%10.62% Which has more risk and volatility, ALGN or BSX? Align Technology has a beta of 1.7, indicating that its share price is 70% more volatile than the S&P 500. Comparatively, Boston Scientific has a beta of 0.61, indicating that its share price is 39% less volatile than the S&P 500. Do analysts prefer ALGN or BSX? Align Technology currently has a consensus price target of $182.67, suggesting a potential upside of 39.15%. Boston Scientific has a consensus price target of $120.71, suggesting a potential upside of 23.37%. Given Align Technology's higher possible upside, research analysts clearly believe Align Technology is more favorable than Boston Scientific.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Align Technology 2 Sell rating(s) 7 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.41Boston Scientific 0 Sell rating(s) 2 Hold rating(s) 23 Buy rating(s) 2 Strong Buy rating(s) 3.00 Does the media prefer ALGN or BSX? In the previous week, Boston Scientific had 7 more articles in the media than Align Technology. MarketBeat recorded 32 mentions for Boston Scientific and 25 mentions for Align Technology. Boston Scientific's average media sentiment score of 1.24 beat Align Technology's score of 0.35 indicating that Boston Scientific is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Align Technology 8 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Neutral Boston Scientific 25 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher earnings & valuation, ALGN or BSX? Boston Scientific has higher revenue and earnings than Align Technology. Align Technology is trading at a lower price-to-earnings ratio than Boston Scientific, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlign Technology$4.00B2.38$421.36M$5.9322.14Boston Scientific$18.49B7.84$1.85B$1.6858.24 SummaryBoston Scientific beats Align Technology on 13 of the 17 factors compared between the two stocks. Get Boston Scientific News Delivered to You Automatically Sign up to receive the latest news and ratings for BSX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BSX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BSX vs. The Competition Export to ExcelMetricBoston ScientificMED PRODUCTS IndustryMedical SectorNYSE ExchangeMarket Cap$145.05B$10.60B$6.15B$21.77BDividend YieldN/A1.91%5.73%3.62%P/E Ratio58.2720.1484.9829.91Price / Sales7.8426.69574.6697.86Price / Cash26.3625.0737.3924.26Price / Book6.553.4612.454.65Net Income$1.85B$208.83M$3.32B$1.01B7 Day Performance0.58%-1.31%0.28%-0.24%1 Month Performance-1.14%2.34%10.12%0.84%1 Year Performance12.44%-7.02%72.36%12.29% Boston Scientific Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BSXBoston Scientific4.8777 of 5 stars$97.84+0.1%$120.71+23.4%+12.7%$145.05B$18.49B58.2753,000Positive NewsUpcoming EarningsALGNAlign Technology4.8018 of 5 stars$129.54+3.0%$196.67+51.8%-41.4%$9.39B$3.96B21.8420,945Analyst ForecastAnalyst RevisionHOLXHologic4.7288 of 5 stars$65.51-3.3%$80.15+22.4%-18.0%$14.57B$4.03B27.187,063Positive NewsHQYHealthEquity4.2106 of 5 stars$93.23+3.0%$121.31+30.1%+10.4%$8.03B$1.27B56.503,120MMSIMerit Medical Systems4.7151 of 5 stars$79.43+0.6%$107.50+35.3%-15.9%$4.70B$1.36B40.327,400News CoverageAnalyst ForecastAMNAMN Healthcare Services4.0513 of 5 stars$19.14+5.4%$23.08+20.6%-49.3%$733.45M$2.98B-2.462,968Analyst ForecastAnalyst RevisionCAHCardinal Health4.9147 of 5 stars$154.26-1.7%$166.00+7.6%+39.0%$36.65B$222.58B23.9257,700Positive NewsDVADaVita4.6992 of 5 stars$123.89-0.1%$155.25+25.3%-23.5%$8.86B$13.16B12.1876,000Analyst ForecastECLEcolab4.8461 of 5 stars$270.16-0.7%$292.29+8.2%+6.0%$76.62B$15.72B36.0748,000Positive NewsAnalyst ForecastHCAHCA Healthcare4.7749 of 5 stars$410.71-1.1%$422.31+2.8%+4.8%$96.10B$70.60B17.26316,000Analyst ForecastMDTMedtronic4.8637 of 5 stars$95.63+0.2%$102.41+7.1%+6.1%$122.66B$33.54B26.3495,000Trending NewsAnalyst ForecastAnalyst Revision Related Companies and Tools Related Companies Align Technology Alternatives Hologic Alternatives HealthEquity Alternatives Merit Medical Systems Alternatives AMN Healthcare Services Alternatives Cardinal Health Alternatives DaVita Alternatives Ecolab Alternatives HCA Healthcare Alternatives Medtronic Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:BSX) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersIs *BSEM* Oversold??BioStem Technologies Inc. (OTC: BSEM) is emerging as one of the most exciting MedTech stories of 2025. The com...Huge Alerts | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredRefund From 1933: Trump’s Reset May Create Instant WealthFed vs. Trump - A War With American Wealth At Stake The Fed's defiance of Trump thickens the plot to contro...American Hartford Gold | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredA Worldwide Gold Lockdown Is Now UnderwayCentral banks around the world are hoarding gold at one of the fastest rates in history — and former Goldman S...Stansberry Research | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Boston Scientific Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Boston Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
